Os melhores médicos de Histerectomia (remoção do útero) no exterior — Página 4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

A Dra. Li Huaifang especializa-se em tumores ginecológicos, distúrbios do pavimento pélvico e cirurgia ginecológica minimamente invasiva. Realizou mais de 10.000 procedimentos minimamente invasivos e mais de 5.000 reparações do pavimento pélvico. O seu trabalho inclui operações oncológicas laparoscópicas e histeroscópicas. Também realiza cirurgia reconstrutiva para prolapso e incontinência. Demonstrou técnicas cirúrgicas em conferências nacionais.

Funções académicas: Membro nacional do Grupo de Disfunção do Pavimento Pélvico (CMA OBGYN). Vice-chefe do Grupo de Pavimento Pélvico da Associação de Obstetrícia e Ginecologia de Xangai. Especialista do Painel de Controlo de Qualidade Ginecológica de Xangai. Participou no 12.º Plano Quinquenal. Atualmente, lidera um subprojeto do 14.º Plano Quinquenal sobre redes degradáveis para o pavimento pélvico. Publicações: mais de 240 artigos, incluindo mais de 50 em SCI. Coautora de livros didáticos e supervisora na Universidade de Tongji com mais de 50 orientandos. As distinções incluem o Prémio de Ciência e Tecnologia Médica de Xangai, o Prémio de Ciência e Tecnologia de Saúde Materno-Infantil da China e prémios de reconstrução do pavimento pélvico em 2006, 2012 e 2015.

O Dr. Jair Bar é oncologista torácico e vice-diretor do Centro de Câncer do Sheba Medical Center. Ele é especializado no tratamento de câncer de pulmão de células não pequenas avançado usando imunoterapia personalizada e tratamentos direcionados. O Dr. Bar possui doutorado em Biologia Molecular e lidera um laboratório de pesquisa focado em resistência à imunoterapia.

• Presidente do Grupo Israelense de Câncer de Pulmão.
• Certificado em Oncologia Médica e Radioterapia Oncológica.
• Trata pacientes no Sheba Medical Center, um dos 10 melhores hospitais do mundo.
• Usa perfil molecular e genético para criar planos precisos de tratamento contra o câncer.

O Dr. Raanan Berger é o diretor do Centro de Câncer do Sheba Medical Center. Ele foi incluído na lista de "Melhores Médicos" da Forbes Israel em 2025. O Dr. Berger é especializado em oncologia geniturinária e trata tumores complexos de próstata com radioterapia. Ele completou um pós-doutorado no Dana-Farber/Harvard Cancer Institute.

• Chefia a unidade de pesquisa clínica focada em oncologia molecular.
• Coautor de mais de 20 artigos revisados por pares sobre câncer de próstata e mutações BRCA.
• Membro da Sociedade Americana de Oncologia Clínica (ASCO).
• Realiza terapia sistêmica e radioterapia em um hospital classificado entre os 10 melhores do mundo.

O primeiro ginecologista credenciado pela SERGS para operar usando duas plataformas robóticas – o Dr. Paul Stanciu é especializado em histerectomias minimamente invasivas no Hospital Académico Ponderas.

• Subespecialista em Oncologia Ginecológica e Cirurgia Robótica
• Formado no Royal Marsden Hospital e em outros centros de renome
• Realiza cirurgias complexas de preservação da fertilidade para pacientes jovens com cancro
• Autor de numerosos artigos científicos sobre técnicas inovadoras

Especializado em oncologia ginecológica no Samsung Medical Center, Kim Tae Joong foca na precisão em procedimentos de histerectomia.

• Especialista em oncoginecologia para a saúde da mulher
• Atua no Samsung Medical Center

O Dr. Lee é especializado em oncoginecologia, focando no atendimento abrangente a pacientes que necessitam de histerectomia no Samsung Medical Center.

• Especialista em técnicas cirúrgicas minimamente invasivas
• Dedicado a preservar a qualidade de vida da paciente após a cirurgia
• Trabalha em uma das principais instituições médicas da Coreia do Sul

O Professor Gilad Ben Baruch especializa-se em oncoginecologia no Centro Médico Assuta, focando-se em cirurgias ginecológicas complexas.

• Especialista em oncoginecologia com anos de experiência especializada
• Realiza técnicas cirúrgicas avançadas para condições ginecológicas
• Trabalha no Centro Médico Assuta, uma instituição de saúde líder

Especialista em histerectomias endoscópicas e laparoscópicas – o Dr. Cohen concentra-se em técnicas minimamente invasivas no Assuta Medical Center.

• Ginecologista com experiência em métodos cirúrgicos avançados
• Realiza procedimentos utilizando tecnologia laparoscópica
• Trabalha no principal hospital privado de Israel

Especialista em Obstetrícia, Ginecologia e Oncologia Ginecológica – O Dr. Amnon traz uma experiência focada em procedimentos de histerectomia no Centro Médico Rambam.

• Especializado tanto em obstetrícia quanto em oncologia ginecológica
• Trabalha no Centro Médico Rambam, uma instituição de saúde líder
• Combina ginecologia geral com formação oncológica avançada

O Dr. Levinstein é especializado em obstetrícia e ginecologia no Rambam Medical Center.

• Especialista em procedimentos de histerectomia
• Foca no atendimento centrado no paciente
• Trabalha em um centro médico de referência

O Professor Ami Fishman é especializado em cirurgias endoscópicas e laparoscópicas para oncologia ginecológica no Herzliya Medical Center.

• Oncoginecologista e cirurgião líder no Herzliya Medical Center
• Chefe do Departamento de Obstetrícia e Ginecologia no Meir Medical Center
• Especializado em doenças do útero, colo do útero e ovários

O Prof. Husslein lidera o Departamento de Obstetrícia e Ginecologia do Hospital Geral de Viena – um dos principais centros médicos da Áustria.

• Especializado em cirurgias ginecológicas avançadas
• Especialista em técnicas minimamente invasivas
• Supervisiona casos complexos em um grande hospital universitário

A Dra. Yuliia Kochet é obstetra-ginecologista e especialista em reprodução humana com 17 anos de experiência e especialização de primeira categoria. É membro da Associação Ucraniana de Medicina Reprodutiva (UARM) e da Sociedade Europeia de Reprodução Humana e Embriologia (ESHRE). Possui experiência em técnicas de reprodução assistida, diagnóstico por ultrassom, histerossalpingografia, histeroscopia, laparoscopia, cirurgia por radiofrequência e tratamento de problemas uterinos e doenças sexualmente transmissíveis. Tem experiência em seminários e conferências internacionais.

A Dra. Iryna Babenko é especialista em fertilidade com 16 anos de experiência, possuindo doutorado (PhD) e diploma de medicina (MD) pela Faculdade de Medicina da Universidade Médica Nacional Pirogov. Ela é especializada em tecnologias de reprodução assistida, tratamento de infertilidade e aborto espontâneo, ginecologia operatória, tratamento de doenças sexualmente transmissíveis, cirurgia endoscópica em ginecologia e diagnóstico por ultrassom. É membro da Associação Ucraniana de Medicina Reprodutiva e da Sociedade Europeia de Reprodução Humana e Embriologia.

Especialista em obstetrícia e ginecologia com mais de 24 anos de experiência – O Dr. Douliotis concentra-se em tratamentos de fertilidade individualizados na clínica Babydust.

• Subespecialista em fertilidade e conceção assistida
• Membro do Royal College of Obstetricians & Gynaecologists
• Oferece tratamentos de fertilidade acessíveis a pacientes internacionais

Professor assistente na Universidade Altınbaş de Istambul com mais de 20 publicações – o Dr. Sismanoglu combina pesquisa acadêmica com experiência clínica em saúde reprodutiva.

• Especializado em tratamento de FIV, obstetrícia e cirurgia de infertilidade
• Membro da Sociedade Europeia de Reprodução Humana e Embriologia (ESHRE)
• Especialista frequentemente destaque na mídia turca sobre saúde reprodutiva
• Equipe multilíngue para apoiar pacientes internacionais

A Dra. Sitanan Panunumpa é diretora médica na Siam Fertility em Banguecoque. Realiza mais de 300 ciclos de FIV e ICSI todos os anos. Também completa mais de 200 cirurgias laparoscópicas ginecológicas anualmente. A Dra. Panunumpa obteve um mestrado em biotecnologia da reprodução humana assistida em Espanha.

• Certificada em medicina reprodutiva pelo Hospital Ramathibodi.
• Membro da Sociedade Americana de Medicina Reprodutiva (ASRM).
• Membro da Sociedade Europeia de Reprodução Humana e Embriologia (ESHRE).
• Trata condições como endometriose, ovários policísticos e miomas uterinos.

Especialista em histerectomia laparoscópica – O Dr. Lee foca-se em técnicas minimamente invasivas no Gachon University Gil Medical Center.

• Oncoginecologista com experiência em operações laparoscópicas
• Realiza a remoção do útero com incisões menores e recuperação mais rápida
• Trabalha num centro médico universitário líder na Coreia do Sul

O Dr. Reyes é especializado em ginecologia e obstetrícia com foco em biologia reprodutiva – sua pesquisa inclui publicações importantes sobre fertilidade e resultados de gravidez.

• Subespecialização em biologia reprodutiva no Hospital Angeles del Pedregal
• Membro da Federação Mexicana de Ginecologia e Obstetrícia
• Coordenador científico do Colégio de Ginecologia de Quintana Roo
• Pesquisa publicada sobre miomectomia e taxas de gravidez por FIV